However, one study suggested that DPP8, a cytosolic protease linked to cancer biology and N-terminal dipeptidyl peptidases, is a potential therapeutic target for T2DM, albeit information on its 3D structure or binding mechanisms was lacking (80). This evidence concerns the gene DPP8 and cancer.